The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Silver, J. M.
* Articles by Endicott, J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Silver, J. M.
* Articles by Endicott, J.
Related Collections
* Miscellaneous Violence/Aggression
* Other Neuroscience
* Other Somatic Therapy
J Neuropsychiatry Clin Neurosci 11:328-335, August 1999
© 1999 American Psychiatric Press, Inc.

Propranolol Treatment of Chronically Hospitalized Aggressive Patients

Jonathan M. Silver, M.D., Stuart C. Yudofsky, M.D., Jonathan A. Slater, M.D., Ruth Kugelmass Gold, M.D., Barri L. Katz Stryer, M.D., Daniel T. Williams, M.D., Henrietta Wolland, M.A. and Jean Endicott, Ph.D.

Received May 27, 1998; revised July 21, 1998; accepted August 13, 1998. From Lenox Hill Hospital, New York University School of Medicine, New York, New York; Baylor College of Medicine, Houston, Texas; and Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, New York, New York. Address correspondence to Dr. Silver, Department of Psychiatry, Lenox Hill Hospital, 100 East 77th Street, New York, NY 10021–1883.

Violent behavior in psychiatric patients may result in long-term hospitalization. There is no FDA-approved psychopharmacologic treatment for aggression. In this study, 20 chronically aggressive hospitalized patients were administered 1 week of placebo followed by an open trial of increasing doses of propranolol. Patients who had an equivocal or definite clinical response were entered into an open add-on double-blind discontinuation study phase. Aggressive behavior was objectively documented throughout the study. After the open phase of the study, 7 patients had a greater than 50% decrease in aggressive behavior. Four patients entered the double-blind discontinuation phase. The clinical course of 3 of those patients was consistent with the positive response to propranolol. The results of this study are consistent with a therapeutic effect of propranolol in some patients with aggressive behavior. Further studies are indicated.

Key Words: Aggression • Propranolol • Beta-Blockers




This article has been cited by other articles:


Home page
AssessmentHome page
E. Stafford and D. G. Cornell
Psychopathy Scores Predict Adolescent Inpatient Aggression
Assessment, March 1, 2003; 10(1): 102 - 112.
[Abstract] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
A. R. POINDEXTER
Phenobarbital, Propranolol, and Aggression
J Neuropsychiatry Clin Neurosci, August 1, 2000; 12(3): 413 - 413.
[Full Text] [PDF]


Home page
JWatch PsychiatryHome page
Does Propranolol Decrease Aggressiveness?
Journal Watch Psychiatry, October 1, 1999; 1999(1001): 13 - 13.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1999 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org